Skip to main content
Clinical Trials/NCT01911299
NCT01911299
Completed
Phase 2

Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders

San Diego State University1 site in 1 country55 target enrollmentMay 2013

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Fetal Alcohol Spectrum Disorders
Sponsor
San Diego State University
Enrollment
55
Locations
1
Primary Endpoint
Changes in cognitive function as measured by performance on neuropsychological tasks of learning/memory, executive functions, and attention
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine whether choline supplementation can improve cognitive functioning of children with prenatal alcohol exposure.

Detailed Description

Despite the known damaging effects of alcohol on the developing fetus and the presence of warning labels on alcoholic beverages, many pregnant women continue to drink alcohol. The consequences include a range of physical, neurological, and behavioral effects referred to as fetal alcohol spectrum disorders (FASD). Unfortunately, there are currently no comprehensive treatments for individuals with FASD. This pilot study will examine whether a nutritional intervention could reduce the severity of cognitive deficits associated with prenatal alcohol exposure. Choline is an essential nutrient, necessary for brain and behavioral development. Animal studies have shown that prenatal or early postnatal choline supplementation can lead to long-lasting cognitive enhancement. Similarly, choline supplementation improves cognitive outcomes among rats exposed to alcohol during development, even when administered postnatally and after alcohol exposure has occurred. The present experiment translates these findings to a clinical population of individuals exposed to heavy prenatal alcohol exposure. Subjects will be randomly assigned to receive daily choline supplementation or placebo control for a period of 6 weeks (approximately 20 subjects per group). Performance on neuropsychological tasks that measure cognitive functioning will be measured prior to treatment and at 6 weeks. These data will provide important information regarding a potential nutritional intervention for fetal alcohol spectrum disorders.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
May 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jennifer Thomas

Associate Director - Center for Behavioral Teratology, San Diego State University

San Diego State University

Eligibility Criteria

Inclusion Criteria

  • Confirmed histories of prenatal alcohol exposure (by review of medical, legal, or social service records or maternal report, if available; information about levels and timing of exposure will be inquired, but not necessary for inclusion)
  • English as primary language

Exclusion Criteria

  • Significant physical (e.g., uncorrected visual impairment, hemiparesis) or psychiatric (e.g., psychosis) disability that would prohibit participation
  • History of neurological condition (e.g., epilepsy)

Outcomes

Primary Outcomes

Changes in cognitive function as measured by performance on neuropsychological tasks of learning/memory, executive functions, and attention

Time Frame: Baseline and 6 weeks

Secondary Outcomes

  • Children's Behavior Checklist (CBCL), Behavioral Rating Inventory of Executive Function (BRIEF)(Baseline and 6 weeks)

Study Sites (1)

Loading locations...

Similar Trials